Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 [Phase 1]

View source ↗

Summary

This update describes a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary efficacy of the investigational drug KRC-01 in cervical canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KRC-01 (KRC-01)

Snippet

Sponsor: Kortuc, Inc. | Conditions: Cervical Cancer | Phase 1 | Status: RECRUITING